About Renin-angiotensin-aldosterone system-blocker-induced angioedema
Renin-angiotensin-aldosterone system-blocker-induced angioedema is a rare disease catalogued by Orphanet (ORPHA:100057). It is associated with the XPNPEP2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Renin-angiotensin-aldosterone system-blocker-induced angioedema trials.
Search ClinicalTrials.gov for "Renin-angiotensin-aldosterone system-blocker-induced angioedema" or filter by Orphanet code ORPHA:100057 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Renin-angiotensin-aldosterone system-blocker-induced angioedema trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Renin-angiotensin-aldosterone system-blocker-induced angioedema. Updated daily.